MediciNova concludes subject enrolment in trial of MN-166
The COMBAT-ALS trial is a randomised, double-blind, placebo-controlled study with a 12-month blinded phase.
Clinical Trial Patient Recruitment
Patient-centric approaches thrive on wearables and remote access in trials
Patient centricity and effective designs drive clinical trial success
Small and mid-sized sponsors demand smart and reliable partnerships
Redefining the future of clinical trials in oncology
Shaping the future of clinical trials in the EU
Recruiting trials dominated in 2024
Clinical trial recruitment companies: Patient recruitment in clinical research
